FR2917427B1 - Inhibiteurs de tace dans le traitement de l'acne - Google Patents
Inhibiteurs de tace dans le traitement de l'acneInfo
- Publication number
- FR2917427B1 FR2917427B1 FR0755819A FR0755819A FR2917427B1 FR 2917427 B1 FR2917427 B1 FR 2917427B1 FR 0755819 A FR0755819 A FR 0755819A FR 0755819 A FR0755819 A FR 0755819A FR 2917427 B1 FR2917427 B1 FR 2917427B1
- Authority
- FR
- France
- Prior art keywords
- acne treatment
- tace inhibitors
- tace
- inhibitors
- acne
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0755819A FR2917427B1 (fr) | 2007-06-18 | 2007-06-18 | Inhibiteurs de tace dans le traitement de l'acne |
CA2690593A CA2690593A1 (fr) | 2007-06-18 | 2008-06-18 | Inhibiteurs de tace dans le traitement de l'acne |
EP08806020A EP2160606A2 (fr) | 2007-06-18 | 2008-06-18 | Inhibiteurs de tace dans le traitement de l'acne |
PCT/FR2008/051085 WO2009004247A2 (fr) | 2007-06-18 | 2008-06-18 | Inhibiteurs de tace dans le traitement de l'acne |
JP2010512749A JP2010532658A (ja) | 2007-06-18 | 2008-06-18 | ざ瘡の治療におけるtaceインヒビター |
US12/640,029 US20100168089A1 (en) | 2007-06-18 | 2009-12-17 | Utilization of tace inhibitors for the treatment of acne |
JP2013206168A JP2014051500A (ja) | 2007-06-18 | 2013-10-01 | ざ瘡の治療におけるtaceインヒビター |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0755819A FR2917427B1 (fr) | 2007-06-18 | 2007-06-18 | Inhibiteurs de tace dans le traitement de l'acne |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2917427A1 FR2917427A1 (fr) | 2008-12-19 |
FR2917427B1 true FR2917427B1 (fr) | 2009-08-21 |
Family
ID=38961832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0755819A Expired - Fee Related FR2917427B1 (fr) | 2007-06-18 | 2007-06-18 | Inhibiteurs de tace dans le traitement de l'acne |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100168089A1 (fr) |
EP (1) | EP2160606A2 (fr) |
JP (2) | JP2010532658A (fr) |
CA (1) | CA2690593A1 (fr) |
FR (1) | FR2917427B1 (fr) |
WO (1) | WO2009004247A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140275108A1 (en) * | 2013-03-15 | 2014-09-18 | Galderma Research & Development | Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
ES2829637T3 (es) * | 2014-12-12 | 2021-06-01 | Dermavant Sciences GmbH | 3,5-dihidroxi-4-isopropil-trans-estilbeno para su uso en el tratamiento tópico del acné |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ID25639A (id) * | 1998-02-19 | 2000-10-19 | American Cyanamid Co | Alkil, aril atau heteroarilamida tersubstitusi n-hidroksi-2-(alkil, aril, atau heteroaril sulfanil, sulfinil atau sulfonil)-3 sebagai inhibitor matriks mataloproteinase |
US20040122011A1 (en) * | 1998-12-23 | 2004-06-24 | Pharmacia Corporation | Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy |
CA2423733A1 (fr) * | 2000-08-31 | 2003-02-14 | Terukage Hirata | Nouveaux derives d'acide propenohydroxamique |
JP2004107220A (ja) * | 2002-09-13 | 2004-04-08 | Mitsubishi Pharma Corp | TNF−α産生抑制剤 |
US20050276807A1 (en) * | 2004-06-15 | 2005-12-15 | Advanced Biotherapy, Inc. | Treatment of acne |
US20060286108A1 (en) * | 2005-06-16 | 2006-12-21 | Bell Katherine A | Topical compositions for the treatment of chronic wounds |
-
2007
- 2007-06-18 FR FR0755819A patent/FR2917427B1/fr not_active Expired - Fee Related
-
2008
- 2008-06-18 WO PCT/FR2008/051085 patent/WO2009004247A2/fr active Application Filing
- 2008-06-18 JP JP2010512749A patent/JP2010532658A/ja active Pending
- 2008-06-18 EP EP08806020A patent/EP2160606A2/fr not_active Withdrawn
- 2008-06-18 CA CA2690593A patent/CA2690593A1/fr not_active Abandoned
-
2009
- 2009-12-17 US US12/640,029 patent/US20100168089A1/en not_active Abandoned
-
2013
- 2013-10-01 JP JP2013206168A patent/JP2014051500A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20100168089A1 (en) | 2010-07-01 |
WO2009004247A3 (fr) | 2009-04-30 |
JP2010532658A (ja) | 2010-10-14 |
JP2014051500A (ja) | 2014-03-20 |
WO2009004247A2 (fr) | 2009-01-08 |
EP2160606A2 (fr) | 2010-03-10 |
FR2917427A1 (fr) | 2008-12-19 |
CA2690593A1 (fr) | 2009-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0916125A2 (pt) | "dispositivo de tratamento" | |
FR2912833B1 (fr) | Panneau pour le traitement acoustique | |
DK2066759T3 (da) | Udfældede vægtningsmidler til anvendelse i borehulsvæsker | |
SE0950453L (sv) | Säkra finansiella transaktioner | |
BRPI0905692A2 (pt) | "bandagem em forma de ilha" | |
BRPI0819582A2 (pt) | "sistema de tratamento de líquido" | |
FR2902324B1 (fr) | Utilisation d'acide ellagique pour le traitement de la canitie | |
DK2144905T3 (da) | Terapeutiske midler | |
FR2907011B1 (fr) | Utilisation de la citrulline pour le traitement des etats de denutrition | |
BRPI0809272A2 (pt) | Compostos de biaril e biheteroaril no tratamento de distúrbios do ferro | |
ITMI20062388A1 (it) | Dispositivo per l'allineamento di ruote | |
HK1139861A1 (en) | Pde7 inhibitors for use in the treatment of movement disorders 7(pde7) | |
FR2899476B1 (fr) | Association du mazindol dans le traitement du deficit de l'attention/hyperactivite | |
DE602007008063D1 (de) | Hydraulikspanner | |
DK2173831T3 (da) | Brøndbehandling | |
BRPI0719514A2 (pt) | Preparações líquidas aquosas compreendendo gatifloxacina | |
FR2934267B1 (fr) | Derives aminophosphiniques utiles dans le traitement de la douleur | |
BRPI0714318A2 (pt) | Utilização de 2-benzoil-imidazopiridinas em terapêutica | |
FR2903999B1 (fr) | Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee | |
FR2917427B1 (fr) | Inhibiteurs de tace dans le traitement de l'acne | |
FR2904003B1 (fr) | Modulateurs du transporteur abcd3 dans le traitement de l'acne ou de l'hyperseborrhee | |
FR2932975B1 (fr) | Vis d'osteosynthese | |
FR2929850B1 (fr) | Inhibiteurs de l'enzyme tyrosinage | |
DE602006019048D1 (de) | EDDH enthaltende Entzunderungslösungen | |
DE602006017118D1 (de) | Feuchtigkeitsspendendes mittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 9 |
|
ST | Notification of lapse |
Effective date: 20170228 |